✦ LIBER ✦

Dopamine D5 receptor gene polymorphism and the risk of levodopa-induced motor fluctuations in patients with Parkinson's disease

✍ Scribed by Jian Wang; Zhuo-Lin Liu; Biao Chen

Book ID: 117471899
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 79 KB
Volume: 308
Category: Article
ISSN: 0304-3940
DOI: 10.1016/s0304-3940(01)01971-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Study of istradefylline in patients with

Study of istradefylline in patients with Parkinson's disease on levodopa with motor fluctuations

✍ Robert A. Hauser; Lisa M. Shulman; Joel M. Trugman; John W. Roberts; Akihisa Mor 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB 👁 1 views

## Abstract The objective of this study was to evaluate the efficacy, safety, and tolerability of istradefylline 20 mg once daily versus placebo as an adjunct to levodopa in subjects with Parkinson's disease (PD) who have motor fluctuations. Istradefylline (KW‐6002) is an adenosine A~2A~ receptor a

Pharmacokinetics of levodopa and 3-omd i

Pharmacokinetics of levodopa and 3-omd in patients with Parkinson's disease and motor fluctuations infected with Helicobacter pylori

✍ Narożańska, E.; Białecka, M.; Adamiak-Giera, U.; Gawrońska-Szklarz, B.; Sołtan, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Gait analysis in patients with Parkinson

Gait analysis in patients with Parkinson's disease and motor fluctuations: Influence of levodopa and comparison with other measures of motor function

✍ John D. O'Sullivan; Catherine M. Said; Louise C. Dillon; Marion Hoffman; Dr. And 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 727 KB

## Abstract Although clinical rating scales and simple timed tests of motor function are widely used to assess motor response to therapy, gait analysis may provide an alternative measure of this response. We studied 15 patients with PD complicated by motor fluctuations, first to determine changes i

Association study of dopamine D2, D3, D4

Association study of dopamine D2, D3, D4 receptor and serotonin transporter gene polymorphisms with sleep attacks in Parkinson's disease

✍ Sebastian Paus; Gert Seeger; Hans M. Brecht; Jürgen Köster; Mahha El-Faddagh; Ma 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 47 KB 👁 1 views

Sleep attacks are a common yet only recently recognized phenomenon in patients with Parkinson's disease (PD). Initially reported to occur only with particular dopamine agonists, sleep attacks have been observed with all dopaminergic drugs. [1][2][3] In the majority of affected patients, sleep attack

Association of dopamine receptor D5 gene

Association of dopamine receptor D5 gene polymorphism with peculiarities of voluntary attention in schizophrenic patients and their relatives

✍ V. E. Golimbet; M. V. Alfimova; I. K. Gritsenko; T. V. Lezheiko; R. Ebstein 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 228 KB

Association of a polymorphism in the dop

Association of a polymorphism in the dopamine-transporter gene with parkinson's disease

✍ Dr. David G. le Couteur; Peter W. Leighton; Sally J. McCann; Susan M. Pond 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 341 KB 👁 1 views

## Abstract The presynaptic dopamine transporter in nigral dopaminergic neurons confers susceptibility to the cytotoxic effects of the neurotoxic metabolite of 1‐methy1‐4‐phenyl‐1,2,3,6‐tetrahydropyridine. Polymorphisms in the dopamine transporter might influence the susceptibility to such toxins.